Health Literacy Clinical Trials
2 recruiting trials for Health Literacy. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Health Literacy clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Haukeland University Hospital (1), University of Aarhus (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is eCardiacRehab (other, 1 trial), followed by Nurse-Led Self-Management Support, GP-follow up.
Track Health Literacy trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
eCardiacRehab - a Hybrid Patient-Centered eHealth Programme
The overall aim of eCardiacRehab trial is to meet rehabilitation needs of patients with coronary artery disease (CAD) regardless of their access to traditional place-based...
Nurse-Led Telehealth for Gout
The aim of this clinical trial is to evaluate whether nurse-led telehealth support helps individuals with gout better manage their condition and adhere to urate-lowering...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Health Literacy, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Health Literacy, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Health Literacy, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.